Search

Showing all 12 results

Sort by

Buy Crysvita (burosumab) Online

From $3,328.84
(0 Reviews)
Crysvita (burosumab) is a human monoclonal antibody medication used to treat X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) in adults and children 6 months of age and older. It is the first and only FDA-approved treatment for XLH.
From $3,328.84

Buy Evkeeza (evinacumab) Online

(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Regeneron Pharmaceuticals, Inc. USAGE: Intravenous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Evkeeza (evinacumab) is a fully human monoclonal antibody that binds to and inhibits angiopoietin-like 3 (ANGPTL3), a protein that plays a key role in lipid metabolism. It is the first FDA-approved treatment that binds to and blocks the function of ANGPTL3.

Buy Isturisa (osilodrostat) Online

From $1,818.17
(0 Reviews)
DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC) MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing's syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing's disease, a type of Cushing's syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing's syndrome (ECS), a type of Cushing's syndrome caused by the body overproducing cortisol on its own.
From $1,818.17

Buy Kerendia (finerenone) Online

From $618.20
(0 Reviews)
Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
From $618.20

Buy Leqvio (inclisiran) Online

$2,671.00
(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Novartis USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Buy Oxlumo (lumasiran) Online

$64,110.43
(0 Reviews)
DISEASE INDICATIONS: Primary hyperoxaluria type 1 (PH1) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxlumo (lumasiran) is a prescription medicine used to treat primary hyperoxaluria type 1 (PH1) in children and adults. PH1 is a rare genetic disorder that causes the body to produce too much of a substance called oxalate. Oxaluria can cause kidney stones, damage to the kidneys and other organs, and even death.

Buy Palynziq (pegvaliase-pqpz) Online

From $321.42
(0 Reviews)
DISEASE INDICATIONS: phenylketonuria (PKU) MANUFACTURER: BioMarin Pharmaceutical Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Palynziq (pegvaliase-pqpz) is a prescription medication used to lower blood levels of phenylalanine (Phe) in adults with phenylketonuria (PKU) who have uncontrolled blood Phe levels above 600 micromol/L (10 mg/dL) on their current treatment. PKU is a rare genetic disorder that prevents the body from breaking down the amino acid phenylalanine. Phenylalanine can build up in the blood and cause serious health problems, such as intellectual disability, seizures, and behavioral problems.
From $321.42

Buy Roszet (rosuvastatin and ezetimibe) Online

(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Althera Life Sciences USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Roszet (rosuvastatin and ezetimibe) is a combination medication used to lower cholesterol levels in the blood. It is a combination of two different medications: rosuvastatin, a statin, and ezetimibe, a cholesterol absorption inhibitor.

Buy Voxzogo (vosoritide) Online

$9,091.90
(0 Reviews)
DISEASE INDICATIONS: Achondroplasia MANUFACTURER: BioMarin Europe Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Voxzogo (vosoritide) is a prescription medicine used to increase linear growth in children with achondroplasia aged 5 years and older with open growth plates. Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth.

Buy Waylivra (volanesorsen) Online

$11,550.76
(0 Reviews)
DISEASE INDICATIONS: Familial chylomicronemia syndrome (FCS) MANUFACTURER: Akcea Therapeutics Ireland Limited USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Waylivra (volanesorsen) is a prescription medication used to treat adults with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. FCS is a rare genetic disorder that causes the body to produce too much of a type of fat called chylomicrons. Chylomicrons can build up in the blood and cause pancreatitis, a serious inflammation of the pancreas.

Buy Zegalogue (dasiglucagon) Online

From $312.85
(0 Reviews)
DISEASE INDICATIONS: Diabetes MANUFACTURER: Zeeland Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zegalogue (dasiglucagon) is a prescription medication used to treat severe hypoglycemia (very low blood sugar) in adults and children with diabetes aged 6 years and older.
From $312.85

Buy Zokinvy (lonafarnib) Online

From $31,401.66
(0 Reviews)
DISEASE INDICATIONS: Progeria MANUFACTURER: Eiger Biopharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Zokinvy (lonafarnib) is a prescription medication used to treat Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL) in children aged 12 months and older. HGPS and PDPL are rare genetic disorders that cause premature aging.
From $31,401.66

Back to Top
Product has been added to your cart